Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment
- 7 November 2020
- journal article
- review article
- Published by Elsevier BV in Pharmacological Research
- Vol. 164, 105277
- https://doi.org/10.1016/j.phrs.2020.105277
Abstract
No abstract availableFunding Information
- I.M. Sechenov First Moscow State Medical University
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
This publication has 196 references indexed in Scilit:
- Colonic inflammation in Parkinson's diseaseNeurobiology of Disease, 2013
- Symptomatic atherosclerosis is associated with an altered gut metagenomeNature Communications, 2012
- Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cellsClinical and Experimental Immunology, 2011
- Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probioticsBioEssays, 2011
- Human oral, gut, and plaque microbiota in patients with atherosclerosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health SurveyBMJ, 2010
- Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcomeAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Central nervous system injury-induced immune deficiency syndromeNature Reviews Neuroscience, 2005
- Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogenJournal of Neural Transmission, 2003
- Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the bruneck studyJournal of the American College of Cardiology, 1999